The FEI has announced an adverse analytical finding involving prohibited substances.
Samples taken at the 80km CEI*1 in Amman (JOR) on 21 May 2016 from the second-placed horse Obama Al Aswad (FEI ID 104DF50, ridden by Nayef Al Fayez (FEI ID 10066952), have returned positive for the banned substance Boldenone, and the controlled medications Dexamethasone, Meloxicam, Phenylbutazone and its metabolite Oxyphenbutazone.
Boldenone, an anabolic steroid, is a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
The corticosteroid Dexamethasone is used to treat inflammatory and auto-immune conditions, while the non-steroidal anti-inflammatory drugs Meloxicam, Phenylbutazone and its metabolite Oxyphenbutazone are used for pain relief.
The athlete has been provisionally suspended from the date of notification (20 June 2016). The horse has also been provisionally suspended for a two-month period.
Further details on this case can be found here.
Notes to Editors:
About Fédération Equestre Internationale (FEI) www.fei.org
The FEI is the world governing body for horse sport recognised by the International Olympic Committee (IOC) and was founded in 1921. Equestrian sport has been part of the Olympic movement since the 1912 Games in Stockholm.
The FEI is the sole controlling authority for all international events in the Olympic sports of Jumping, Dressage and Eventing, as well as Driving, Endurance, Vaulting and Reining.
The FEI became one of the first international sports governing bodies to govern and regulate global para sport alongside its seven able-bodied disciplines when Para-Equestrian Dressage joined its ranks in 2006. The FEI now governs all international competitions for Para-Equestrian Dressage and Para-Driving.
For more information, please contact:
Ruth Grundy
Manager Press Relations
ruth.grundy@fei.org
+41 78 750 61 45
20 Years at #1: Your best source of news about the Olympics is www.aroundtherings.com, for subscribers only